Annual Report 2021 for Vistin Pharma ASA
Vistinpharmaasa-2021-12-31-en
Kurs
+3,41%
Likviditet
0,91 MNOK
Kalender
| Tid* | ||
| 2025-10-30 | 07:30 | Kvartalsrapport 2025-Q3 |
| 2025-08-15 | 07:30 | Kvartalsrapport 2025-Q2 |
| 2025-05-22 | N/A | Årsstämma |
| 2025-04-25 | 07:30 | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | 07:00 | Bokslutskommuniké 2024 |
| 2024-11-06 | - | X-dag bonusutdelning VISTN 0.5 |
| 2024-11-06 | - | X-dag halvårsutdelning VISTN 0.5 |
| 2024-10-31 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-23 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-05 | - | X-dag bonusutdelning VISTN 0.5 |
| 2024-06-05 | - | X-dag halvårsutdelning VISTN 0.5 |
| 2024-05-23 | - | Årsstämma |
| 2024-04-24 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-16 | - | Bokslutskommuniké 2023 |
| 2024-01-23 | - | X-dag ordinarie utdelning VISTN 0.75 NOK |
| 2024-01-23 | - | X-dag bonusutdelning VISTN 0.75 |
| 2023-10-25 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-23 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-23 | - | X-dag ordinarie utdelning VISTN 0.00 NOK |
| 2023-05-22 | - | Årsstämma |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-10-26 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-19 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-24 | - | X-dag ordinarie utdelning VISTN 0.00 NOK |
| 2022-05-19 | - | Årsstämma |
| 2022-04-27 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-10-28 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-19 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-21 | - | X-dag ordinarie utdelning VISTN 0.50 NOK |
| 2021-05-21 | - | X-dag bonusutdelning VISTN 0.5 |
| 2021-05-20 | - | Årsstämma |
| 2021-04-23 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-19 | - | Bokslutskommuniké 2020 |
| 2020-10-30 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-28 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-24 | - | Extra Bolagsstämma 2020 |
| 2020-05-20 | - | X-dag ordinarie utdelning VISTN 1.00 NOK |
| 2020-05-19 | - | Årsstämma |
| 2020-04-23 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-28 | - | Bokslutskommuniké 2019 |
| 2019-10-25 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-29 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-23 | - | X-dag ordinarie utdelning VISTN 0.00 NOK |
| 2019-05-22 | - | Årsstämma |
| 2019-04-25 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-19 | - | Bokslutskommuniké 2018 |
| 2018-10-25 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-30 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-25 | - | X-dag ordinarie utdelning VISTN 1.00 NOK |
| 2018-05-08 | - | Årsstämma |
| 2018-04-26 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-27 | - | Bokslutskommuniké 2017 |
| 2017-11-03 | - | X-dag bonusutdelning VISTN 7 |
| 2017-11-02 | - | Extra Bolagsstämma 2017 |
| 2017-10-27 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-31 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-26 | - | X-dag ordinarie utdelning VISTN 1.00 NOK |
| 2017-05-24 | - | Årsstämma |
| 2017-04-26 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-28 | - | Bokslutskommuniké 2016 |
| 2016-10-31 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-30 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-25 | - | X-dag ordinarie utdelning VISTN 0.60 NOK |
| 2016-05-24 | - | Årsstämma |
| 2016-04-28 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-23 | - | Bokslutskommuniké 2015 |
| 2015-10-29 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-26 | - | Kvartalsrapport 2015-Q2 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Oslo, Norway, 27 April 2022
Please find attached the Annual Report for 2021 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full year result presented on 17 February 2022.
The annual report for 2021 will also be made available on www.vistin.com.
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97 05 36 21
Alexander.karlsen@vistin.com
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.